Emergent BioSolutions Inc. (EBS)
$5.76-$0.18 (-3.09%) Today
Donald W. Degolyer - DirectorDonald W. Degolyer - DirectorEmergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.
https://www.emergentbiosolutions.comSEC filings for EBS on EDGAR
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 1 | 3,000 | $25K |
| Tax withholding / forfeiture | 4 | 8,417 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
56 Form 4 filings on record, the earliest from Oct 17, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Paul Anthony Williams - Officer | Open-market sale | Common Stock | 3,000 | $8.40 | $25K | |
| Paul Anthony Williams - Officer | Tax withholding / forfeiture | Common Stock | 694 | $8.00 | $6K | |
| Richard S. Lindahl - Officer | Tax withholding / forfeiture | Common Stock | 3,964 | $8.00 | $32K | |
 Coleen Glessner - Officer | Tax withholding / forfeiture | Common Stock | 2,018 | $8.00 | $16K | |
 William Hartzel - Officer | Tax withholding / forfeiture | Common Stock | 1,741 | $8.00 | $14K | |
| Sujata Tyagi Dayal - Director | Grant or award | Common Stock | 25,344 | $0.00 | - | |
| Sujata Tyagi Dayal - Director | Open-market sale | Common Stock | 12,781 | $8.36 | $107K | |
| Sujata Tyagi Dayal - Director | Open-market sale | Common Stock | 980 | $8.94 | $9K | |
| Sujata Tyagi Dayal - Director | Grant or award | Stock Option (Right to Buy) | 11,296 | $0.00 | - | |
| Donald W. Degolyer - Director | Grant or award | Common Stock | 25,344 | $0.00 | - | |
| Donald W. Degolyer - Director | Open-market sale | Common Stock | 14,527 | $8.36 | $121K | |
| Donald W. Degolyer - Director | Open-market sale | Common Stock | 954 | $8.96 | $9K | |
| Donald W. Degolyer - Director | Grant or award | Stock Option (Right to Buy) | 11,296 | $0.00 | - | |
| Keith Katkin - Director | Grant or award | Common Stock | 25,344 | $0.00 | - | |
| Keith Katkin - Director | Open-market sale | Common Stock | 15,481 | $8.28 | $128K | |
| Keith Katkin - Director | Grant or award | Stock Options (Right to Buy) | 11,296 | $0.00 | - | |
| Marvin L. White - Director | Grant or award | Common Stock | 25,344 | $0.00 | - | |
| Marvin L. White - Director | Grant or award | Stock Option (Right to Buy) | 11,296 | $0.00 | - | |
| John D. Fowler Jr. - Director | Grant or award | Common Stock | 25,344 | $0.00 | - | |
| John D. Fowler Jr. - Director | Grant or award | Stock Option (Right to Buy) | 11,296 | $0.00 | - | |
 Ronald Richard - Director | Grant or award | Common Stock | 25,344 | $0.00 | - | |
| Ronald Richard - Director | Grant or award | Stock Option (Right to Buy) | 11,296 | $0.00 | - | |
| Kathryn C. Zoon - Director | Grant or award | Common Stock | 25,344 | $0.00 | - | |
| Kathryn C. Zoon - Director | Open-market sale | Common Stock | 16,145 | $8.36 | $135K | |
| Kathryn C. Zoon - Director | Open-market sale | Common Stock | 1,057 | $8.97 | $9K | |
| Kathryn C. Zoon - Director | Grant or award | Stock Option (Right to Buy) | 11,296 | $0.00 | - | |
 Neal Franklin Fowler - Director | Grant or award | Stock Option (Right to Buy) | 11,296 | $0.00 | - | |
| Neal Franklin Fowler - Director | Grant or award | Common Stock | 25,344 | $0.00 | - | |
| Zsolt Harsanyi - Officer | Grant or award | Common Stock | 25,344 | $0.00 | - | |
| Zsolt Harsanyi - Officer | Grant or award | Stock Option (Right to Buy) | 11,296 | $0.00 | - | |
| Paul Anthony Williams - Officer | Grant or award | Common Stock | 100,111 | $0.00 | - | |
| Simon C. Lowry - Officer | Grant or award | Common Stock | 100,111 | $0.00 | - | |
| Coleen Glessner - Officer | Grant or award | Common Stock | 100,111 | $0.00 | - | |
| Richard S. Lindahl - Officer | Grant or award | Common Stock | 162,680 | $0.00 | - | |
| Jessica Perl - Officer | Grant or award | Common Stock | 104,282 | $0.00 | - | |
| William Hartzel - Officer | Grant or award | Common Stock | 100,111 | $0.00 | - | |
 Joseph C. Papa - Officer | Grant or award | Common Stock | 187,708 | $0.00 | - | |
| Paul Anthony Williams - Officer | Open-market sale | Common Stock | 4,000 | $8.44 | $34K | |
| Joseph C. Papa - Officer | Tax withholding / forfeiture | Common Stock | 37,055 | $8.44 | $313K | |
| Joseph C. Papa - Officer | Grant or award | Employee Stock Option (Right to buy) | 252,194 | $0.00 | - | |
| John D. Fowler Jr. - Director | Grant or award | Common Stock | 5,006 | $8.99 | $45K | |
| Simon C. Lowry - Officer | Tax withholding / forfeiture | Common Stock | 10,636 | $8.44 | $90K | |
| Simon C. Lowry - Officer | Grant or award | Employee Stock Option (Right to buy) | 44,834 | $0.00 | - | |
| William Hartzel - Officer | Tax withholding / forfeiture | Common Stock | 9,493 | $8.44 | $80K | |
| William Hartzel - Officer | Grant or award | Employee Stock Option (Right to buy) | 44,834 | $0.00 | - | |
| Jessica Perl - Officer | Tax withholding / forfeiture | Common Stock | 6,465 | $8.44 | $55K | |
| Jessica Perl - Officer | Grant or award | Employee Stock Option (Right to buy) | 46,702 | $0.00 | - | |
| Paul Anthony Williams - Officer | Tax withholding / forfeiture | Common Stock | 9,397 | $8.44 | $79K | |
| Paul Anthony Williams - Officer | Grant or award | Employee Stock Option (Right to buy) | 44,834 | $0.00 | - | |
| Richard S. Lindahl - Officer | Tax withholding / forfeiture | Common Stock | 23,650 | $8.44 | $200K | |
| Richard S. Lindahl - Officer | Grant or award | Employee Stock Option (Right to buy) | 72,856 | $0.00 | - | |
| Coleen Glessner - Officer | Tax withholding / forfeiture | Common Stock | 8,199 | $8.44 | $69K | |
| Coleen Glessner - Officer | Grant or award | Employee Stock Option (Right to buy) | 44,834 | $0.00 | - |
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR | |
| - | - | - | - | View on EDGAR | |
| - | - | - | - | View on EDGAR |
Emergent BioSolutions Inc. (EBS) had 5 insider filings in the last 90 days, with the most recent on 2026-07-02. The full record for EBS runs to 56 Form 4 filings, the earliest from 2024-10-17. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of EBS were filed in the last 90 days. 1 purchase is on record for this company.
1 insider sale of EBS was filed in the last 90 days, totaling $25K.
This page tracks EBS Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add EBS to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
